openPR Logo
Press release

Viscosupplementation Market Growth Evolution 2018-2026 By Top Key Players: Anika Therapeutics, Inc., Sanofi, Zimmer Holdings Inc., Lifecore Biomedical, LLC, and LG Life Sciences Limited, Bioventus, Ferring B.V

11-06-2018 09:07 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Viscosupplementation Market Growth Evolution 2018-2026 By Top

The global Viscosupplementation market is anticipated to reach USD 6.6 billion by 2026 according to a new research published by Polaris Market Research. Based on the assessments circulated by the World Health Organization, the worldwide people of the age of 65 years or more is estimated to ascend from 7% from 2000 to 16% till 2050.

Major key Player: -

Seikagaku Corporation
Lifecore Biomedical LLC.
Zimmer Holdings Inc
Bioventus
Ferring B.V.
Sanofi
Anika Therapeutics, Inc.
LG Life Sciences Ltd.

Request for a Sample copy of this Report @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-free-sample

Viscosupplementation is a minimally invasive procedure helps reducing the joint ache and increases the efficient condition of the osteoarthritic joint. Viscosupplementation involves the injection of a thick fluid known as hyaluronate into the knee. Hyaluronic acid is an elastic substance which is naturally secreted by mesothelial cells present in the body joints.

Osteoarthritis the most common type of arthritis which is characterized by degeneration of cartilage, tissues, and loss of function that cover the ends of the bones in a joint. A related outcome of the increase in the elderly population will be an addition in the occurrences of obesity and osteoarthritis. Alongside developing inclination for obtrusive surgeries, worldwide increment in the population has projected to drive the Viscosupplementation Market during the forecast period.

The Viscosupplementation Market is anticipated to witness a huge development over the forecast period owing to the growing frequency of osteoarthritis, wounds, gingivitis, and ulcers. Developing base of the geriatric patients is a rendering driver of the Viscosupplementation industry. In addition, increasing global occurrence of osteoarthritis leads to demand for Viscosupplementation. According to Centers for Disease Control and Prevention (CDC) 2015, over 30 million people in the U.S. suffered osteoarthritis and around 10% people over 55 years suffered knee pain.

On the basis of product type three injection dominated the market. It was narrowly followed by single injection. The prolonged presence in market justifies its dominance. Owing to the existence of highly neglected medical needs in developing economies, in the Latin America, awareness about the uses of insignificantly intrusive methods, and expanding income, the viscosupplementation Market is projected to develop at a productive rate during the upcoming decade. Single injection is expected to be the fastest developing product type. This is attributed to decreased clinical visits, lower adverse impacts and related discomfort.

Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/inquire-before-buying

Key Findings from the study suggest Asia Pacific Viscosupplementation market has the largest share and is presumed to keep up its position amid the forecast years. This position is mainly due to the existence of sizeable base of geriatric people, which is more vulnerable to ailments, for example, osteoarthritis and rheumatoid joint inflammation. Additionally, developing interest for negligibly obtrusive techniques is a huge influence adding to the substantial market of Asia Pacific.

Browse Complete Report Summary @ https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viscosupplementation Market Growth Evolution 2018-2026 By Top Key Players: Anika Therapeutics, Inc., Sanofi, Zimmer Holdings Inc., Lifecore Biomedical, LLC, and LG Life Sciences Limited, Bioventus, Ferring B.V here

News-ID: 1354310 • Views:

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected to
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach

All 5 Releases


More Releases for Viscosupplementation

Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia